Kindred At Home | |
1328 Greenbrier-dear Road, Anniston, Alabama 36207 | |
(256) 835-7101 | |
Name | Kindred At Home |
---|---|
Location | 1328 Greenbrier-dear Road, Anniston, Alabama |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 17151 |
Ownership Type | Proprietary |
Service Area Zip Codes | 35131, 35905, 36201, 36202, 36203, 36204, 36205, 36206, 36207, 36250, 36253, 36254, 36260, 36262, 36264, 36265, 36268, 36269, 36271, 36272, 36273, 36277, 36279 |
NPI Number | 1841229754 |
Organization Name | CENTERWELL CERTIFIED HEALTHCARE CORP. |
Doing Business As | CENTERWELL HOME HEALTH |
Address | 1900 Leighton Ave Ste 102, Anniston, AL 36207 |
Phone Number | 256-835-7101 |
News Archive
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.
› Verified 6 days ago
Quality Rating: |
News Archive
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 97.4 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 98.9 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 97.6 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.6 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 85.3 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.4 | 96.4 |
News Archive
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.
› Verified 6 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 78.5 | 79.6 |
How often patients got better at getting in and out of bed | 75.3 | 81.1 |
How often patients got better at bathing | 84.6 | 82.3 |
How often patients’ breathing improved | 82.1 | 82.8 |
How often patients’ wounds improved or healed after an operation | 98.1 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 68.9 | 75 |
How often home health patients had to be admitted to the hospital | 17.9 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.5 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 87.3 | 94 |
News Archive
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.
› Verified 6 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.
› Verified 6 days ago
The patient survey data of Kindred At Home is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 92 | 88 |
Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 88 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 91 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 84 | 78 |
News Archive
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.
› Verified 6 days ago
Kindred At Home Location: 1328 Greenbrier-dear Road, Anniston, Alabama 36207 Ratings: Phone: (256) 835-7101 | |
Amedisys Home Health Of Anniston Location: 171 Town Center Dr, Suite Mps-4, Anniston, Alabama 36205 Ratings: Phone: (256) 820-2503 |